Dr. Kabos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2006 - 2009
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2003 - 2006
Comenius UniversityClass of 1998
Certifications & Licensure
CA State Medical License 2005 - Present
CO State Medical License 2007 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer Start of enrollment: 2016 Nov 14
Publications & Presentations
PubMed
- Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells.Ashley V Ward, Duncan Riley, Kirsten E Cosper, Jessica Finlay-Schultz, Heather M Brechbuhl
Breast Cancer Research. 2025-03-07 - Metabolic Switch in Endocrine Resistant Estrogen Receptor Positive Breast Cancer.Heather M Brechbuhl, Amy Han, Kiran Vinod Paul, Travis Nemkov, Srinivas Ramachandran
Biorxiv. 2024-12-29 - Obesity-driven changes in breast tissue exhibit a pro-angiogenic extracellular matrix signature.Ellen E Bamberg, Mark Maslanka, Kiran Vinod-Paul, Sharon Sams, Erica Pollack
Matrix Biology Plus. 2024-12-01
Press Mentions
Are Oncologists Jumping the Gun with the 21-Gene Assay?April 13th, 2017
Technology at UCHealth Helps Save Hair During ChemotherapyAugust 31st, 2016
Tablets Show Promise as an Alternative to Chemotherapy in CU Cancer Center Member’s Breast Cancer StudyFebruary 1st, 2024
Grant Support
- Novel dietary interventions for reducing obesity-associated breast cancerUNIVERSITY OF COLORADO DENVER2022–2026
- Novel dietary interventions for reducing obesity-associated breast cancerUNIVERSITY OF COLORADO DENVER2022–2026
- Hormone Receptor Regulation of RNA Polymerase IIIUNIVERSITY OF COLORADO DENVER2022–2026
- Hormone Receptor Regulation of RNA Polymerase IIIUNIVERSITY OF COLORADO DENVER2022–2026
- Hormone Receptor Regulation of RNA Polymerase IIIUNIVERSITY OF COLORADO DENVER2022–2026
- Hormone Receptor Regulation of RNA Polymerase IIIUNIVERSITY OF COLORADO DENVER2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
